Javascript doit fonctionner ! Activez-le et rechargez cette page.
Le Rézo de JeuxDeMots
• Types de relations
• Types de noeuds
• Consolider
le terme
  Options  
             

  Filtrage type relations : +   - (ex: 4, 12, 18, 36, 444, 555, 777)
  Filtrage valeur :          min   max
  Filtrage type noeuds :   +   - (ex: 4, 6, 8, 9, 10, 12, 18, 36, 444, 555, 777)

  Présentation de sortie :   (ex: -rien-, cloud, nicecloud)
 

'en:anticoagulant effect increased'
(id=7273559 ; fe=en:anticoagulant effect increased ; type=1 ; niveau=200 ; luminosité=25 ; somme entrante=1628 creation date=2017-06-26 touchdate=2025-07-16 08:55:35.000)
≈ 23 relations sortantes

  1. en:anticoagulant effect increased -- r_associated #0: 35 / 1 -> effet anticoagulant augmenté
    n1=en:anticoagulant effect increased | n2=effet anticoagulant augmenté | rel=r_associated | relid=0 | w=35
  2. en:anticoagulant effect increased -- r_associated #0: 30 / 0.857 -> en:increased fibrinolysis (finding)
    n1=en:anticoagulant effect increased | n2=en:increased fibrinolysis (finding) | rel=r_associated | relid=0 | w=30
  3. en:anticoagulant effect increased -- r_associated #0: 30 / 0.857 -> en:purpura
    n1=en:anticoagulant effect increased | n2=en:purpura | rel=r_associated | relid=0 | w=30
  4. en:anticoagulant effect increased -- r_associated #0: 30 / 0.857 -> en:thrombocytopenic purpura
    n1=en:anticoagulant effect increased | n2=en:thrombocytopenic purpura | rel=r_associated | relid=0 | w=30
  5. en:anticoagulant effect increased -- r_associated #0: 25 / 0.714 -> en:anticoagulant
    n1=en:anticoagulant effect increased | n2=en:anticoagulant | rel=r_associated | relid=0 | w=25
  6. en:anticoagulant effect increased -- r_associated #0: 24 / 0.686 -> en:purpura fulminans
    n1=en:anticoagulant effect increased | n2=en:purpura fulminans | rel=r_associated | relid=0 | w=24
  7. en:anticoagulant effect increased -- r_associated #0: 20 / 0.571 -> effet anticoagulant diminué
    n1=en:anticoagulant effect increased | n2=effet anticoagulant diminué | rel=r_associated | relid=0 | w=20
  8. en:anticoagulant effect increased -- r_associated #0: 20 / 0.571 -> en:anticoagulant disorders
    n1=en:anticoagulant effect increased | n2=en:anticoagulant disorders | rel=r_associated | relid=0 | w=20
  9. en:anticoagulant effect increased -- r_associated #0: 20 / 0.571 -> en:anticoagulant effect decreased
    n1=en:anticoagulant effect increased | n2=en:anticoagulant effect decreased | rel=r_associated | relid=0 | w=20
  10. en:anticoagulant effect increased -- r_associated #0: 20 / 0.571 -> en:clotting decreased
    n1=en:anticoagulant effect increased | n2=en:clotting decreased | rel=r_associated | relid=0 | w=20
  11. en:anticoagulant effect increased -- r_associated #0: 20 / 0.571 -> en:disseminated intravascular coagulation adverse event
    n1=en:anticoagulant effect increased | n2=en:disseminated intravascular coagulation adverse event | rel=r_associated | relid=0 | w=20
  12. en:anticoagulant effect increased -- r_associated #0: 20 / 0.571 -> en:hemorrhage laboratory terms (smq)
    n1=en:anticoagulant effect increased | n2=en:hemorrhage laboratory terms (smq) | rel=r_associated | relid=0 | w=20
  13. en:anticoagulant effect increased -- r_associated #0: 20 / 0.571 -> en:lee-white clotting time prolonged
    n1=en:anticoagulant effect increased | n2=en:lee-white clotting time prolonged | rel=r_associated | relid=0 | w=20
  14. en:anticoagulant effect increased -- r_associated #0: 20 / 0.571 -> en:peliosis
    n1=en:anticoagulant effect increased | n2=en:peliosis | rel=r_associated | relid=0 | w=20
  15. en:anticoagulant effect increased -- r_associated #0: 20 / 0.571 -> en:thrombocytopenia
    n1=en:anticoagulant effect increased | n2=en:thrombocytopenia | rel=r_associated | relid=0 | w=20
  16. en:anticoagulant effect increased -- r_associated #0: 20 / 0.571 -> en:thromboplastin decreased
    n1=en:anticoagulant effect increased | n2=en:thromboplastin decreased | rel=r_associated | relid=0 | w=20
  17. en:anticoagulant effect increased -- r_associated #0: 20 / 0.571 -> péliose
    n1=en:anticoagulant effect increased | n2=péliose | rel=r_associated | relid=0 | w=20
  18. en:anticoagulant effect increased -- r_associated #0: 20 / 0.571 -> Purkinje (réseau de)
    n1=en:anticoagulant effect increased | n2=Purkinje (réseau de) | rel=r_associated | relid=0 | w=20
  19. en:anticoagulant effect increased -- r_associated #0: 20 / 0.571 -> purpura
    n1=en:anticoagulant effect increased | n2=purpura | rel=r_associated | relid=0 | w=20
  20. en:anticoagulant effect increased -- r_associated #0: 20 / 0.571 -> purpura fulminans
    n1=en:anticoagulant effect increased | n2=purpura fulminans | rel=r_associated | relid=0 | w=20
  21. en:anticoagulant effect increased -- r_associated #0: 20 / 0.571 -> purpura thrombocytopénique
    n1=en:anticoagulant effect increased | n2=purpura thrombocytopénique | rel=r_associated | relid=0 | w=20
  22. en:anticoagulant effect increased -- r_associated #0: 20 / 0.571 -> thrombocytopénie
    n1=en:anticoagulant effect increased | n2=thrombocytopénie | rel=r_associated | relid=0 | w=20
  23. en:anticoagulant effect increased -- r_associated #0: 20 / 0.571 -> thrombopénie
    n1=en:anticoagulant effect increased | n2=thrombopénie | rel=r_associated | relid=0 | w=20
≈ 45 relations entrantes

  1. purpura --- r_associated #0: 150 --> en:anticoagulant effect increased
    n1=purpura | n2=en:anticoagulant effect increased | rel=r_associated | relid=0 | w=150
  2. en:purpura --- r_associated #0: 148 --> en:anticoagulant effect increased
    n1=en:purpura | n2=en:anticoagulant effect increased | rel=r_associated | relid=0 | w=148
  3. péliose --- r_associated #0: 146 --> en:anticoagulant effect increased
    n1=péliose | n2=en:anticoagulant effect increased | rel=r_associated | relid=0 | w=146
  4. en:thrombocytopenia --- r_associated #0: 135 --> en:anticoagulant effect increased
    n1=en:thrombocytopenia | n2=en:anticoagulant effect increased | rel=r_associated | relid=0 | w=135
  5. thrombocytopénie --- r_associated #0: 131 --> en:anticoagulant effect increased
    n1=thrombocytopénie | n2=en:anticoagulant effect increased | rel=r_associated | relid=0 | w=131
  6. purpura fulminans --- r_associated #0: 95 --> en:anticoagulant effect increased
    n1=purpura fulminans | n2=en:anticoagulant effect increased | rel=r_associated | relid=0 | w=95
  7. en:purpura fulminans --- r_associated #0: 92 --> en:anticoagulant effect increased
    n1=en:purpura fulminans | n2=en:anticoagulant effect increased | rel=r_associated | relid=0 | w=92
  8. en:anticoagulant effect decreased --- r_associated #0: 47 --> en:anticoagulant effect increased
    n1=en:anticoagulant effect decreased | n2=en:anticoagulant effect increased | rel=r_associated | relid=0 | w=47
  9. effet anticoagulant diminué --- r_associated #0: 44 --> en:anticoagulant effect increased
    n1=effet anticoagulant diminué | n2=en:anticoagulant effect increased | rel=r_associated | relid=0 | w=44
  10. en:clotting decreased --- r_associated #0: 41 --> en:anticoagulant effect increased
    n1=en:clotting decreased | n2=en:anticoagulant effect increased | rel=r_associated | relid=0 | w=41
  11. en:thrombocytopenic purpura --- r_associated #0: 39 --> en:anticoagulant effect increased
    n1=en:thrombocytopenic purpura | n2=en:anticoagulant effect increased | rel=r_associated | relid=0 | w=39
  12. en:peliosis --- r_associated #0: 37 --> en:anticoagulant effect increased
    n1=en:peliosis | n2=en:anticoagulant effect increased | rel=r_associated | relid=0 | w=37
  13. en:thromboplastin decreased --- r_associated #0: 32 --> en:anticoagulant effect increased
    n1=en:thromboplastin decreased | n2=en:anticoagulant effect increased | rel=r_associated | relid=0 | w=32
  14. thrombopénie --- r_associated #0: 32 --> en:anticoagulant effect increased
    n1=thrombopénie | n2=en:anticoagulant effect increased | rel=r_associated | relid=0 | w=32
  15. en:anticoagulant disorders --- r_associated #0: 31 --> en:anticoagulant effect increased
    n1=en:anticoagulant disorders | n2=en:anticoagulant effect increased | rel=r_associated | relid=0 | w=31
  16. en:lee-white clotting time prolonged --- r_associated #0: 31 --> en:anticoagulant effect increased
    n1=en:lee-white clotting time prolonged | n2=en:anticoagulant effect increased | rel=r_associated | relid=0 | w=31
  17. purpura thrombocytopénique --- r_associated #0: 31 --> en:anticoagulant effect increased
    n1=purpura thrombocytopénique | n2=en:anticoagulant effect increased | rel=r_associated | relid=0 | w=31
  18. Purkinje (réseau de) --- r_associated #0: 30 --> en:anticoagulant effect increased
    n1=Purkinje (réseau de) | n2=en:anticoagulant effect increased | rel=r_associated | relid=0 | w=30
  19. en:hemorrhage laboratory terms (smq) --- r_associated #0: 30 --> en:anticoagulant effect increased
    n1=en:hemorrhage laboratory terms (smq) | n2=en:anticoagulant effect increased | rel=r_associated | relid=0 | w=30
  20. effet anticoagulant augmenté --- r_associated #0: 29 --> en:anticoagulant effect increased
    n1=effet anticoagulant augmenté | n2=en:anticoagulant effect increased | rel=r_associated | relid=0 | w=29
  21. en:disseminated intravascular coagulation adverse event --- r_associated #0: 26 --> en:anticoagulant effect increased
    n1=en:disseminated intravascular coagulation adverse event | n2=en:anticoagulant effect increased | rel=r_associated | relid=0 | w=26
  22. en:increased fibrinolysis (finding) --- r_associated #0: 26 --> en:anticoagulant effect increased
    n1=en:increased fibrinolysis (finding) | n2=en:anticoagulant effect increased | rel=r_associated | relid=0 | w=26
  23. en:thrombopeny --- r_associated #0: 23 --> en:anticoagulant effect increased
    n1=en:thrombopeny | n2=en:anticoagulant effect increased | rel=r_associated | relid=0 | w=23
  24. en:thrombopenia --- r_associated #0: 21 --> en:anticoagulant effect increased
    n1=en:thrombopenia | n2=en:anticoagulant effect increased | rel=r_associated | relid=0 | w=21
  25. Thrombopénie --- r_associated #0: 20 --> en:anticoagulant effect increased
    n1=Thrombopénie | n2=en:anticoagulant effect increased | rel=r_associated | relid=0 | w=20
  26. purpurique --- r_associated #0: 11 --> en:anticoagulant effect increased
    n1=purpurique | n2=en:anticoagulant effect increased | rel=r_associated | relid=0 | w=11
  27. Pelger-Huët (anomalie de) --- r_associated #0: 10 --> en:anticoagulant effect increased
    n1=Pelger-Huët (anomalie de) | n2=en:anticoagulant effect increased | rel=r_associated | relid=0 | w=10
  28. Purpura --- r_associated #0: 10 --> en:anticoagulant effect increased
    n1=Purpura | n2=en:anticoagulant effect increased | rel=r_associated | relid=0 | w=10
  29. Thrombocytopénie --- r_associated #0: 10 --> en:anticoagulant effect increased
    n1=Thrombocytopénie | n2=en:anticoagulant effect increased | rel=r_associated | relid=0 | w=10
  30. en:purpuric --- r_associated #0: 10 --> en:anticoagulant effect increased
    n1=en:purpuric | n2=en:anticoagulant effect increased | rel=r_associated | relid=0 | w=10
  31. purpurinurie --- r_associated #0: 10 --> en:anticoagulant effect increased
    n1=purpurinurie | n2=en:anticoagulant effect increased | rel=r_associated | relid=0 | w=10
  32. thrombolytique (traitement) --- r_associated #0: 10 --> en:anticoagulant effect increased
    n1=thrombolytique (traitement) | n2=en:anticoagulant effect increased | rel=r_associated | relid=0 | w=10
  33. purpura annulaire télangiectasique de Majocchi --- r_associated #0: 5 --> en:anticoagulant effect increased
    n1=purpura annulaire télangiectasique de Majocchi | n2=en:anticoagulant effect increased | rel=r_associated | relid=0 | w=5
  34. purpura en cocarde infantile postinfectieux de Seidlmayer --- r_associated #0: 5 --> en:anticoagulant effect increased
    n1=purpura en cocarde infantile postinfectieux de Seidlmayer | n2=en:anticoagulant effect increased | rel=r_associated | relid=0 | w=5
  35. purpura hyperimmunoglobulinémique --- r_associated #0: 5 --> en:anticoagulant effect increased
    n1=purpura hyperimmunoglobulinémique | n2=en:anticoagulant effect increased | rel=r_associated | relid=0 | w=5
  36. purpura immuno-allergique --- r_associated #0: 5 --> en:anticoagulant effect increased
    n1=purpura immuno-allergique | n2=en:anticoagulant effect increased | rel=r_associated | relid=0 | w=5
  37. purpura néonatal --- r_associated #0: 5 --> en:anticoagulant effect increased
    n1=purpura néonatal | n2=en:anticoagulant effect increased | rel=r_associated | relid=0 | w=5
  38. purpura papuleux en gants et en chaussettes --- r_associated #0: 5 --> en:anticoagulant effect increased
    n1=purpura papuleux en gants et en chaussettes | n2=en:anticoagulant effect increased | rel=r_associated | relid=0 | w=5
  39. purpura psychogène --- r_associated #0: 5 --> en:anticoagulant effect increased
    n1=purpura psychogène | n2=en:anticoagulant effect increased | rel=r_associated | relid=0 | w=5
  40. purpura psychogénique --- r_associated #0: 5 --> en:anticoagulant effect increased
    n1=purpura psychogénique | n2=en:anticoagulant effect increased | rel=r_associated | relid=0 | w=5
  41. purpura rhumatoïde --- r_associated #0: 5 --> en:anticoagulant effect increased
    n1=purpura rhumatoïde | n2=en:anticoagulant effect increased | rel=r_associated | relid=0 | w=5
  42. purpura sénile de Bateman --- r_associated #0: 5 --> en:anticoagulant effect increased
    n1=purpura sénile de Bateman | n2=en:anticoagulant effect increased | rel=r_associated | relid=0 | w=5
  43. purpura thrombopénique idiopathique --- r_associated #0: 5 --> en:anticoagulant effect increased
    n1=purpura thrombopénique idiopathique | n2=en:anticoagulant effect increased | rel=r_associated | relid=0 | w=5
  44. purpura thrombotique thrombocytopénique héréditaire --- r_associated #0: 5 --> en:anticoagulant effect increased
    n1=purpura thrombotique thrombocytopénique héréditaire | n2=en:anticoagulant effect increased | rel=r_associated | relid=0 | w=5
  45. purpura vasculaire --- r_associated #0: 5 --> en:anticoagulant effect increased
    n1=purpura vasculaire | n2=en:anticoagulant effect increased | rel=r_associated | relid=0 | w=5
Le service Rézo permet d'énumérer les relations existant pour un terme. Ce service est interrogeable par programme.
Projet JeuxDeMots - url: http://www.jeuxdemots.org
contact: mathieu.lafourcade@lirmm.fr